NCT01866020View on ClinicalTrials.gov

Diagnosis of Invasive Pulmonary Aspergillosis (IPA) in Critically Ill Patients

CompletedOBSERVATIONAL
Enrollment

85

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

January 31, 2015

Conditions
Survival After IPARisk Factors for IPA
Trial Locations (1)

20246

University Medical Center Hamburg-Eppendorf, Hamburg

All Listed Sponsors
lead

Universitätsklinikum Hamburg-Eppendorf

OTHER

NCT01866020 - Diagnosis of Invasive Pulmonary Aspergillosis (IPA) in Critically Ill Patients | Biotech Hunter | Biotech Hunter